News
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...
Internally, records released this month revealed that Prasad had overridden career FDA staff to limit emergency use approvals for updated shots from Moderna and Novavax.
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President ...
Why Vinay Prasad Had to Go at FDA The gene therapy chief wanted to block fast-track drug approvals. By The Editorial Board Follow ...
Who is Vinay Prasad? US FDA's top regulator exits agency after controversy over Sarepta gene therapy Dr Vinay Prasad has resigned from the FDA after less than three months amid controversy over ...
(CNN) — Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency in May, has resigned less than three months into the job ...
WASHINGTON (AP) — The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. A spokesperson for the Department of Health and Human Services says Prasad did ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. Prasad joined the agency in May.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results